Allogene Therapeutics logo
Allogene Therapeutics ALLO
$ 2.19 4.03%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Allogene Therapeutics EV/EBITDA Ratio 2011-2024 | ALLO

Annual EV/EBITDA Ratio Allogene Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-7.54 -18.2 -10.5 -4.1 - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-4.1 -18.2 -10.1